Manufacturing method affects mitochondrial DNA release and extracellular vesicle composition in stored red blood cells

Vox Sanguinis

Volumn 111, Issue 1, 2016, Pages 22-32

  Bakkour, S ^a   Acker, J P ^b,c   Chafets, D M ^a   Inglis, H C ^a   Norris, P J ^a,d   Lee, T H ^a   Busch, M P ^a,d  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b CANADIAN BLOOD SERVICES   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

blood component; extracellular vesicles; manufacture; microparticles; mitochondrial DNA; process; red blood cells; storage

Indexed keywords

MITOCHONDRIAL DNA;

APHERESIS; APHERESIS DEVICE; ARTICLE; BLOOD; DAMAGE ASSOCIATED MOLECULAR PATTERN; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE COUNT; ERYTHROCYTE PRESERVATION; EXOSOME; FLOW CYTOMETRY; HEMATOLOGICAL PROCEDURE; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; THROMBOCYTE;

EID: 84977585708     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12390     Document Type: Article

References (52)

1. Hansen AL, Kurach JD, Turner TR, et al.: The effect of processing method on the in vitro characteristics of red blood cell products. Vox Sang 2015; 108:350–358
2. Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007; 81:1–5
3. Lee YL, King MB, Gonzalez RP, et al.: Blood transfusion products contain mitochondrial DNA damage-associated molecular patterns: a potential effector of transfusion-related acute lung injury. J Surg Res 2014; 191:286–289
4. Land WG: Transfusion-Related Acute Lung Injury: the Work of DAMPs. Transfus Med Hemother 2013; 40:3–13
5. Belizaire RM, Prakash PS, Richter JR, et al.: Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. J Am Coll Surg 2012; 214:648–655
6. Cardo LJ, Wilder D, Salata J: Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apher Sci 2008; 38:117–125
7. Bicalho B, Pereira AS, Acker JP: Buffy coat (top/bottom)- and whole-blood filtration (top/top)-produced red cell concentrates differ in size of extracellular vesicles. Vox Sang 2015; 109:214–220
8. Danesh A, Inglis HC, Jackman RP, et al.: Exosomes from red blood cell units bind to monocytes and induce proinflammatory cytokines, boosting T-cell responses in vitro. Blood 2014; 123:687–696
9. Acker JP, Hansen AL, Kurach JD, et al.: A quality monitoring program for red blood cell components: in vitro quality indicators before and after implementation of semiautomated processing. Transfusion 2014; 54:2534–2543
10. Palmer DS, Birch P, O'Toole J, et al.: Flow cytometric determination of residual white blood cell levels in preserved samples from leukoreduced blood products. Transfusion 2008; 48:118–128
11. Lauring AS, Lee TH, Martin JN, et al.: Lack of Evidence for mtDNA as a Biomarker of Innate Immune Activation in HIV Infection. PLoS ONE 2012; 7:e50486
12. Inglis H, Norris P, Danesh A: Techniques for the analysis of extracellular vesicles using flow cytometry. J Vis Exp 2015; 97:e52484. doi:10.3791/52484.
13. Inglis HC, Danesh A, Shah A, et al.: Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytometry A 2015; 87:1052–1063
14. Boudreau LH, Duchez AC, Cloutier N, et al.: Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A(2) to promote inflammation. Blood 2014; 124:2173–2183
15. Muszynski JA, Bale J, Nateri J, et al.: Supernatants from stored red blood cell (RBC) units, but not RBC-derived microvesicles, suppress monocyte function in vitro. Transfusion 2015; 55:1937–1945
16. Sparrow RL, Patton KA: Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 2004; 44:722–730
17. Hérault O, Binet C, Rico A, et al.: Evaluation of performance of white blood cell reduction filters: an original flow cytometric method for detection and quantification of cell-derived membrane fragments. Cytometry 2001; 45:277–284
18. Bontadini A, Tazzari PL, Manfroi S, et al.: Apoptosis in leucodepleted packed red blood cells. Vox Sang 2002; 83:35–41
19. Seghatchian J, Krailadsiri P, Dilger P, et al.: Cytokines as quality indicators of leucoreduced red cell concentrates. Transfus Apher Sci 2002; 26:43–46
20. Glenister KM, Sparrow RL: Level of platelet-derived cytokines in leukoreduced red blood cells is influenced by the processing method and type of leukoreduction filter. Transfusion 2010; 50:185–189
21. Chiu RW, Chan LY, Lam NY, et al.: Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem 2003; 49:719–726
22. Lam NY, Rainer TH, Chiu RW, et al.: Plasma mitochondrial DNA concentrations after trauma. Clin Chem 2004; 50:213–216
23. Nakahira K, Kyung SY, Rogers AJ, et al.: Circulating mitochondrial DNA in patients in the ICU as a marker of mortality: derivation and validation. PLoS Med 2013; 10:e1001577
24. McIlroy DJ, Bigland M, White AE, et al.: Cell necrosis-independent sustained mitochondrial and nuclear DNA release following trauma surgery. J Trauma Acute Care Surg 2015; 78:282–288
25. Kung CT, Hsiao SY, Tsai TC, et al.: Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room. J Transl Med 2012; 10:130
26. Zhang Q, Raoof M, Chen Y, et al.: Circulating mitochondrial damps cause inflammatory responses to injury. Nature 2010; 464:104–107
27. Puskarich MA, Shapiro NI, Trzeciak S, et al.: Plasma levels of mitochondrial DNA in patients presenting to the emergency department with sepsis. Shock 2012; 38:337–340
28. Cognasse F, Aloui C, Anh Nguyen K, et al.: Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers. Transfusion 2015; doi:10.1111/trf.13373.
29. Kent MW, Kelher MR, West FB, et al.: The pro-inflammatory potential of microparticles in red blood cell units. Transfusion Med 2014; 24:176–181
30. Sparrow RL, Chan KSK: Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations. J Prot 2012; 76:211–219
31. Chan KS, Sparrow RL: Microparticle profile and procoagulant activity of fresh-frozen plasma is affected by whole blood leukoreduction rather than 24-hour room temperature hold. Transfusion 2014; 54:1935–1944
32. Johnson L, Kwok M, Marks DC: Preparation of red blood cell concentrates and plasma units from whole blood held overnight using a hollow-fibre separation system. Transfus Med 2015; 25:13–19
33. Krailadsiri P, Seghatchian J, MacGregor I, et al.: The effects of leukodepletion on the generation and removal of microvesicles and prion protein in blood components. Transfusion 2006; 46:407–417
34. Hess JR, Sparrow RL, van der Meer PF, et al.: Red blood cell hemolysis during blood bank storage: using national quality management data to answer basic scientific questions. Transfusion 2009; 49:2599–2603
35. Sugawara A, Nollet KE, Yajima K, et al.: Preventing platelet-derived microparticle formation-and possible side effects-with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010; 134:771–775
36. Picker SM, Radojska SM, Gathof BS: In vitro quality of red blood cells (RBCs) collected by multicomponent apheresis compared to manually collected RBCs during 49 days of storage. Transfusion 2007; 47:687–696
37. Rubin O, Crettaz D, Canellini G, et al.: Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008; 95:288–297
38. Sparrow RL, Sran A, Healey G, et al.: In vitro measures of membrane changes reveal differences between red blood cells stored in saline-adenine-glucose-mannitol and AS-1 additive solutions: a paired study. Transfusion 2014; 54:560–568
39. Krysko DV, Agostinis P, Krysko O, et al.: Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011; 32:157–164
40. Barteneva NS, Fasler-Kan E, Bernimoulin M, et al.: Circulating microparticles: square the circle. BMC Cell Biol 2013; 14:23
41. Zhang Q, Itagaki K, Hauser CJ: Mitochondrial DNA is released by shock and activates neutrophils via p38 MAP kinase. Shock 2010; 34:55–59
42. Sun S, Sursal T, Adibnia Y, et al.: Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways. PLoS ONE 2013; 8:e59989
43. Collins LV, Hajizadeh S, Holme E, et al.: Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukoc Biol 2004; 75:995–1000
44. Zhang JZ, Liu Z, Liu J, et al.: Mitochondrial DNA induces inflammation and increases TLR9/NF-kappaB expression in lung tissue. Int J Mol Med 2014; 33:817–824
45. Angelillo-Scherrer A: Leukocyte-derived microparticles in vascular homeostasis. Circ Res 2012; 110:356–369
46. Italiano JE Jr, Mairuhu AT, Flaumenhaft R: Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010; 17:578–584
47. Rubin O, Canellini G, Delobel J, et al.: Red blood cell microparticles: clinical relevance. Transfus Med Hemother 2012; 39:342–347
48. Fergusson DA, Hébert P, Hogan DL, et al.: Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial. JAMA 2012; 308:1443–1451
49. Lacroix J, Hébert PC, Fergusson DA, et al.: Age of transfused blood in critically ill adults. N Engl J Med 2015; 372:1410–1418
50. Steiner ME, Ness PM, Assmann SF, et al.: Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med 2015; 372:1419–1429
51. Pereira A: Will clinical studies elucidate the connection between the length of storage of transfused red blood cells and clinical outcomes? An analysis based on the simulation of randomized controlled trials. Transfusion 2013; 53:34–40
52. Chin-Yee IH, Chin-Yee BH, Pereira A: Clinical trials and the age of blood: ABLE but still wanting. Transfus Med 2015; 25:349–350.